| Dr Samah M Shehadeh, MD | |
|
Ave Los Astros 1766, Golden Hill, Dorado, PR 00646 | |
| (787) 529-3102 | |
| Not Available |
| Full Name | Dr Samah M Shehadeh |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | Ave Los Astros 1766, Dorado, Puerto Rico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982815643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 15488 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metropolitan Hospital | San juan, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hope Med Psc | 5294138566 | 6 |
| Special Care Infusion Center, Inc | 9335158351 | 2 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Hospital Menonita De Cayey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750317764 PECOS PAC ID: 2466449657 Enrollment ID: O20040429000135 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Mennonite General Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851320394 PECOS PAC ID: 6709843964 Enrollment ID: O20041220000467 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Special Care Infusion Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497707251 PECOS PAC ID: 9335158351 Enrollment ID: O20060419000177 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Hope Health Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609186212 PECOS PAC ID: 6608001854 Enrollment ID: O20131024001557 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Entity Name | Hope Med Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265003198 PECOS PAC ID: 5294138566 Enrollment ID: O20210723001727 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samah M Shehadeh, MD Hima Plaza 1 , Ave Luis Munoz Marin, Suite #312, Caguas, PR 00726 Ph: (787) 529-3102 | Dr Samah M Shehadeh, MD Ave Los Astros 1766, Golden Hill, Dorado, PR 00646 Ph: (787) 529-3102 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to launch RE-ALIGN, a global, Phase II trial evaluating the safety and pharmacokinetics of dabigatran etexilate in 400 patients who have mechanical heart valves.
Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).
Agilent Technologies Inc. today announced it has developed a new method to identify radioactive iodine using inductively coupled plasma mass spectrometry (ICP-MS). The method will first be used by Gakushuin University in Japan, with a donated Agilent 7700 ICP-MS System.
Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.
Researchers at Seattle's Institute for Systems Biology and their collaborators looked at the electronic health records of nearly 630,000 patients who were tested for SARS-CoV-2, and found stark disparities in COVID-19 outcomes - odds of infection, hospitalization, and in-hospital mortality - between White and non-White minority racial and ethnic groups.
› Verified 9 days ago
Ileana Eileen Ocasio Melendez, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Carr 693, Doctors Center Clinic, Plaza Dorada 24, Dorado, PR 00646 Phone: 787-665-2222 Fax: 787-665-0101 | |
Dr. Omar Segarra-alonso, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 Villa Este, Dorado, PR 00646 Phone: 787-692-6565 | |
Dr. Alberto Zamot Carmona, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Carr 693, Esquina Ave. Jose Efrain, Doctors Heath Center Dorado Clinic # 24, Plaza Dorada, Dorado, PR 00646 Phone: 787-626-2233 Fax: 787-665-0101 | |
Samayra Miranda Rodriguez, M. D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Doctors Center Clinics Plaza Dorada Shopping Mall, Dorado, PR 00646 Phone: 787-665-2222 | |
Dr. Mary Carmen Quiles, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Carr 696 Ave Efron, Dorado, PR 00646 Phone: 787-625-3030 | |
Meilyn Reyes-perez, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 845 Carr 693 Suite 24, Doctor Center Clinic Dorado, Dorado, PR 00646 Phone: 787-665-2222 | |
Dr. Angel Vinuela, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 448 Dorado Bch E, Dorado, PR 00646 Phone: 787-361-4008 |